Compare NNBR & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNBR | BYSI |
|---|---|---|
| Founded | 1980 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.8M | 67.9M |
| IPO Year | 1996 | 2016 |
| Metric | NNBR | BYSI |
|---|---|---|
| Price | $1.52 | $1.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 519.0K | 17.3K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.60 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $770,657,000.00 | N/A |
| Revenue This Year | $8.60 | N/A |
| Revenue Next Year | $6.30 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $1.16 |
| 52 Week High | $2.63 | $3.44 |
| Indicator | NNBR | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.73 | 53.99 |
| Support Level | $1.51 | $1.64 |
| Resistance Level | $1.66 | $1.83 |
| Average True Range (ATR) | 0.12 | 0.12 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 42.45 | 53.13 |
NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.